Clinical Trial Update: Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial results for belimumab added to background standard therapy in systemic lupus erythematosus have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2018-08-15